Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:20 2025-12-05 pm EST			Pre-market 08:17:32 am
99.72 ^USD	-1.16%		99.45	-0.27%

07:29am	Saskatchewan adds Capvaxive to publicly funded adult immunization program	RE
Dec. 05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	206,957	193,588	281,302	276,259	251,648	247,507	-	-
Change	-	-6.46%	45.31%	-1.79%	-8.91%	-1.65%	-	-
Enterprise Value (EV) ¹	230,686	218,594	298,801	304,221	275,517	272,847	262,182	245,293
Change	-	-5.24%	36.69%	1.81%	-9.44%	-0.97%	-3.91%	-6.44%
P/E ratio	29.4x	14.9x	19.4x	779x	14.8x	12.9x	13.4x	10x
PBR	8.18x	5.07x	6.12x	7.34x	5.44x	4.6x	3.79x	3.03x
PEG	-	0.2x	1.7x	-8x	0x	0.9x	-3.82x	0.3x
Capitalization / Revenue	4.31x	3.97x	4.75x	4.6x	3.92x	3.82x	3.63x	3.45x
EV / Revenue	4.81x	4.49x	5.04x	5.06x	4.29x	4.21x	3.84x	3.42x
EV / EBITDA	11.2x	10.5x	11.3x	30.2x	9.88x	9x	8.46x	7.14x
EV / EBIT	13.6x	12.4x	13.3x	49x	11.8x	10.2x	9.85x	7.92x
EV / FCF	41.4x	25.2x	20.3x	33.3x	15.2x	10.8x	11.3x	9.74x
FCF Yield	2.41%	3.97%	4.92%	3.01%	6.57%	9.24%	8.83%	10.3%
Dividend per Share ²	2.48	2.64	2.8	2.96	3.12	3.234	3.382	3.537
Rate of return	3.03%	3.44%	2.52%	2.72%	3.14%	3.24%	3.39%	3.55%
EPS ²	2.78	5.14	5.71	0.14	6.74	7.739	7.467	9.942
Distribution rate	89.2%	51.4%	49%	2,114%	46.3%	41.8%	45.3%	35.6%
Net sales ¹	47,994	48,704	59,283	60,115	64,168	64,763	68,205	71,777
EBITDA ¹	20,570	20,910	26,431	10,083	27,897	30,301	30,981	34,331
EBIT ¹	16,945	17,696	22,522	6,211	23,398	26,838	26,619	30,986
Net income ¹	7,067	13,049	14,519	365	17,117	19,470	18,394	24,512
Net Debt ¹	23,729	25,006	17,499	27,962	23,869	25,340	14,675	-2,214
Reference price ²	81.80	76.64	110.95	109.02	99.48	99.72	99.72	99.72
Nbr of stocks (in thousands)	2,530,034	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	-	-
Announcement Date	2/4/21	2/3/22	2/2/23	2/1/24	2/4/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	12.89x	4.21x	9x	3.24%	248B
ELI LILLY AND COMPANY	44.17x	14.63x	32.47x	0.59%	905B
JOHNSON & JOHNSON	19.27x	5.41x	14.97x	2.56%	487B
ABBVIE INC.	52.81x	7.48x	17.71x	2.89%	400B
ROCHE HOLDING AG	18.03x	4.54x	11.37x	3.18%	330B
ASTRAZENECA PLC	27.29x	5.16x	15.31x	1.78%	281B
NOVARTIS AG	18.36x	4.97x	11.67x	3.07%	255B
NOVO NORDISK A/S	13.42x	4.8x	9.94x	3.76%	214B
AMGEN INC.	25.21x	6.12x	10.51x	2.9%	178B
GILEAD SCIENCES, INC.	17.68x	5.58x	10.21x	2.73%	150B
Average	24.91x	6.29x	14.32x	2.67%	344.69B
Weighted average by Cap.	29.57x	7.85x	18.14x	2.26%